Zogenix Gets $10M Loan Facility

San Diego-based Zogenix, a pharmaceutical firm focused on neuroscience, said today that it has received $3.5M from a $10M loan facility from GE HealthCare Financial Services. The firm will use the funding to finance launch of its first product, an acute treatment for migraines. Zogenix is venture-backed by Clarus Ventures, Domain Associates, Life Science Angels, Scale Ventures and Thomas, McNerney & Partners.